- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VITA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| Fr | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| Di | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 2 | ASX | ||
| Mo | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 1 | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Half Year Presentation | - | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Dividend/Distribution - VLS | - | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Half Year Accounts | - | ASX | ||
| 26.06. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 24.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 23.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 22.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 18.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 17.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 7,135 | +1,21 % | Why Green Thumb Industries Stock Stumbled Today | ||
| INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
| ALNYLAM PHARMACEUTICALS | 381,40 | -1,19 % | dpa-AFX-Überblick: UNTERNEHMEN - Die wichtigsten Meldungen vom Wochenende | ROUNDUP: Guirassy-Doppelpack rettet BVB gegen Union DORTMUND - Serhou Guirassy schlenderte zufrieden auf seinen gelben Socken über den Rasen des Dortmunder Stadions. Auf den Torjäger war beim BVB... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 33,800 | -1,17 % | Why Nektar Therapeutics Rippled Higher This Week | ||
| CASSAVA SCIENCES | 1,848 | -0,03 % | Cassava Sciences, Inc.: Cassava Reports Q2 2025 Financials Results and Provides Business Update | Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyRecent appointment of experienced... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 1,500 | -7,75 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification | - Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events - NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS'' or the... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 21,690 | +0,56 % | Acadia Names Konstantina Katcheves as Senior VP, Chief Business & Strategy Officer | ||
| CATALYST PHARMACEUTICALS | 17,030 | -1,67 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals | CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule Holdings amends, converts 8% debentures | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results | Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company") a mental health care company focused on... ► Artikel lesen | |
| ZELIRA THERAPEUTICS | 0,208 | +13,04 % | ZELIRA THERAPEUTICS LIMITED: Preliminary Final Report | ||
| OPUS GENETICS | 1,120 | +3,70 % | Opus Genetics, Inc.: Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions | RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases... ► Artikel lesen | |
| SOLIGENIX | 2,860 | -5,92 % | Soligenix Tumbles After Company Publishes Paper | ||
| ANI PHARMACEUTICALS | 82,50 | +1,23 % | ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance | Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on an organic basisTotal Rare Disease quarterly net revenues of... ► Artikel lesen |
Das Unternehmen VITA LIFE SCIENCES LIMITED kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITA LIFE SCIENCES LIMITED finden Sie auf Wallstreet Online.